In last trading session, Clover Health Investments Corp (NASDAQ:CLOV) saw 7.01 million shares changing hands with its beta currently measuring 1.91. Company’s recent per share price level of $2.74 trading at -$0.1 or -3.52% at ring of the bell on the day assigns it a market valuation of $1.39B. That closing price of CLOV’s stock is at a discount of -77.74% from its 52-week high price of $4.87 and is indicating a premium of 56.93% from its 52-week low price of $1.18.
For Clover Health Investments Corp (CLOV), analysts’ consensus is at an average recommendation of Hold while assigning it a mean rating of 2.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 0 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Clover Health Investments Corp (NASDAQ:CLOV) trade information
Upright in the red during last session for losing -3.52%, in the last five days CLOV remained trading in the red while hitting it’s week-highest on Friday, 06/20/25 when the stock touched $2.74 price level, adding 13.29% to its value on the day. Clover Health Investments Corp’s shares saw a change of 119.20% in year-to-date performance and have moved -3.18% in past 5-day. Clover Health Investments Corp (NASDAQ:CLOV) showed a performance of -14.11% in past 30-days.
Wall Street analysts have assigned a consensus price target of 2.5 to the stock, which implies a fall of -9.6% to its current value. Analysts have been projecting 1.8 as a low price target for the stock while placing it at a high target of 6. It follows that stock’s current price would jump 34.31% in reaching the projected high whereas dropping to the targeted low would mean a gain of 34.31% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -237.67% during past 5 years.
Clover Health Investments Corp (NASDAQ:CLOV)’s Major holders
VANGUARD GROUP INC is the top institutional holder at CLOV for having 17.35 million shares of worth $21.33 million. And as of 2024-06-30, it was holding 3.5581 of the company’s outstanding shares.
The second largest institutional holder is RENAISSANCE TECHNOLOGIES LLC, which was holding about 11.27 million shares on 2024-06-30. The number of shares represents firm’s hold over 2.3123 of outstanding shares, having a total worth of $13.86 million.
